Hemoglobin, lead exposure, and intelligence quotient: Effect modifcation by the DRD2 taq IA polymorphism

Environmental Health Perspectives

Volumn 119, Issue 1, 2011, Pages 144-149

  Roy, Ananya ^a   Hu, Howard ^b   Bellinger, David C ^c,d   Mukherjee, Bhramar ^b   Modali, Rama ^e   Nasaruddin, Khaja ^e   Schwartz, Joel ^c   Wright, Robert O ^c,d,f   Ettinger, Adrienne S ^c,f   Palaniapan, Kavitha ^g   Balakrishnan, Kalpana ^g  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e Bioserve Bio Technologies India Pvt Ltd   (India)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Blood lead; Children; Dopamine; Hemoglobin; India; Intelligence quotient

Indexed keywords

HEMOGLOBIN; LEAD;

ARTICLE; CHILD; COGNITION; DRD2 GENE; ENVIRONMENTAL EXPOSURE; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HOMOZYGOSITY; HUMAN; INTELLIGENCE QUOTIENT; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WILD TYPE;

ANEMIA, IRON-DEFICIENCY; CHILD; CHILD, PRESCHOOL; COGNITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HEMOGLOBINS; HUMANS; INDIA; INTELLIGENCE TESTS; LEAD; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2;

ANIMALIA;

EID: 78751542069     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0901878     Document Type: Article

References (59)

1. Ahamed M, Singh S, Behari JR, Kumar A, Siddiqui MK. 2007. Interaction of lead with some essential trace metals in the blood of anemic children from Lucknow, India. Clin Chim Acta 377(1-2):92-97.
2. Ahamed M, Verma S, Kumar A, Siddiqui MK. 2005. Environmental exposure to lead and its correlation with biochemical indices in children. Sci Total Environ 346(1- 3):48-55.
3. Beard J. 2007. Recent evidence from human and animal studies regarding iron status and infant development. J Nutr 137(2):524S-530S.
4. Beard JL, Connor JR. 2003. Iron status and neural functioning. Annu Rev Nutr 23:41-58.
5. Beard JL, Felt B, Schallert T, Burhans M, Connor JR, Georgieff MK. 2006. Moderate iron defciency in infancy: biology and behavior in young rats. Behav Brain Res 170(2):224-232.
6. Berman SM, Noble EP, Antolin T, Sheen C, Conner BT, Ritchie T. 2006. P300 development during adolescence: effects of DRD2 genotype. Clin Neurophysiol 117(3):649-659.
7. Brockel BJ, Cory-Slechta DA. 1999. Lead-induced decrements in waiting behavior: involvement of D2-like dopamine receptors. Pharmacol Biochem Behav 63(3):423-434.
8. Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. 2003. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348(16):1517-1526.
9. CDC (Centers for Disease Control and Prevention). 1997. Update: Blood lead levels-United States, 1991-1994. MMWR Morb Mortal Wkly Rep 46(7):141-146.
10. Collins FS, Brooks LD, Chakravarti A. 1999. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 8:1229-1231.
11. Cory-Slechta DA. 1995. Relationships between lead-induced learning impairments and changes in dopaminergic, cho-linergic, and glutamatergic neurotransmitter system functions. Annu Rev Pharmacol Toxicol 35:391-415.
12. Cory-Slechta DA. 1996. Legacy of lead exposure: consequences for the central nervous system. Otolaryngol Head Neck Surg 114(2):224-226.
13. Cory-Slechta DA. 1997. Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity. Neurotoxicology 18(3):673-688.
14. Cory-Slechta DA. 2003. Lead-induced impairments in complex cognitive function: offerings from experimental studies. Child Neuropsychol 9(1):54-75.
15. Cory-Slechta DA, Brockel BJ, O'Mara DJ. 2002. Lead exposure and dorsomedial striatum mediation of fixed interval schedule-controlled behavior. Neurotoxicology 23(3):313-327.
16. Cory-Slechta DA, O'Mara DJ, Brockel BJ. 1998. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure. J Pharmacol Exp Ther 286(2):794-805.
17. Darcheville JC, Riviere V, Wearden JH. 1993. Fixed-interval performance and self-control in infants. J Exp Anal Behav 60(2):239-254.
18. Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, et al. 1999. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72(1):148-156.
19. Erikson KM, Jones BC, Beard JL. 2000. Iron defciency alters dopamine transporter functioning in rat striatum. J Nutr 130(11):2831-2837.
20. Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. 2001. Iron defciency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav 69(3-4):409-418.
21. Froehlich TE, Lanphear BP, Dietrich KN, Cory-Slechta DA, Wang N, Kahn RS. 2007. Interactive effects of a DRD4 polymorphism, lead, and sex on executive functions in children. Biol Psychiatry 62(3):243-249.
22. Govoni S, Lucchi L, Missale C, Memo M, Spano PF, Trabucchi M. 1986. Effect of lead exposure on dopaminer gic receptors in rat striatum and nucleus accumbens. Brain Res 381(1):138-142.
23. IIPS (International Institute for Population Sciences) and Macro International. 2007. National Family Health Survey (NFHS-3) 2005-2006, India. Mumbai:IIPS.
24. Jain NB, Hu H. 2006. Childhood correlates of blood lead levels in Mumbai and Delhi. Environ Health Perspect 114:466-470.
25. Jocham G, Klein TA, Neumann J, von Cramon DY, Reuter M, Ullsperger M. 2009. Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. J Neurosci 29(12):3695-3704.
26. Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, et al. 2009. Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988- 2004. Pediatrics 123(3):e376-e385.
27. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, et al. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4(3):290-296.
28. Kaiser R, Henderson AK, Daley WR, Naughton M, Khan MH, Rahman M, et al. 2001. Blood lead levels of primary school children in Dhaka, Bangladesh. Environ Health Perspect 109:563-566.
29. Kamat VV. 1967. Measuring Intelligence of Indian Children. Bombay, India:Oxford University Press.
30. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. 2005. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 113:894-899.
31. Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T. 2006. Long-lasting neural and behavioral effects of iron defciency in infancy. Nutr Rev 64(5 pt 2):S34-S43.
32. Lozoff B, Georgieff MK. 2006. Iron defciency and brain development. Semin Pediatr Neurol 13(3):158-165.
33. McCann JC, Ames BN. 2007. An overview of evidence for a causal relation between iron defciency during development and defcits in cognitive or behavioral function. Am J Clin Nutr 85(4):931-945.
34. Meiergerd SM, Patterson TA, Schenk JO. 1993. D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem 61(2):764-767.
35. Nichani V, Li WI, Smith MA, Noonan G, Kulkarni M, Kodavor M, et al. 2006. Blood lead levels in children after phase-out of leaded gasoline in Bombay, India. Sci Total Environ 363(1-3):95-106.
36. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. 1991. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48(7):648-654.
37. Noble EP, Gottschalk LA, Fallon JH, Ritchie TL, Wu JC. 1997. D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet 74(2):162-166.
38. Pacit I, Drtilkova I, Kopeckova M, Theiner P, Sery O, Cermakova N. 2010. The association between TaqI A polymorphism of ANKK1 (DRD2) gene and ADHD in the Czech boys aged between 6 and 13 years. Neuro Endocrinol Lett 31(1):131-136.
39. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK, et al. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3(3):256-260.
40. Pokora MJ, Richfeld EK, Cory-Slechta DA. 1996. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. J Neurochem 67(4):1540-1550.
41. Ponce G, Perez-Gonzalez R, Aragues M, Palomo T, Rodriguez-Jimenez R, Jimenez-Arriero MA, et al. 2009. The ANKK1 kinase gene and psychiatric disorders. Neurotox Res 16(1):50-59.
42. Qaqish BF, Liang KY. 1992. Marginal models for correlated binary responses with multiple classes and multiple levels of nesting. Biometrics 48(3):939-950.
43. Reuter M, Peters K, Schroeter K, Koebke W, Lenardon D, Bloch B, et al. 2005. The influence of the dopaminergic system on cognitive functioning: a molecular genetic approach. Behav Brain Res 164(1):93-99.
44. Reuter M, Roth S, Holve K, Hennig J. 2006. Identifcation of first candidate genes for creativity: a pilot study. Brain Res 1069(1):190-197.
45. Rosner B. 1983. Percentage points for a generalized ESD many-outier procedure. Technometrics 25(2):165-172.
46. Roy A, Bellinger D, Hu H, Schwartz J, Ettinger AS, Wright RO, et al. 2009a. Lead exposure and behavior among young children in Chennai, India. Environ Health Perspect 117:1607-1611.
47. Roy A, Hu H, Bellinger DC, Palaniapan K, Wright RO, Schwartz J, et al. 2009b. Predictors of blood lead in children in Chennai, India. Int J Occup Environ Health 15(4):351-359.
48. Seifer R. 2001. Socioeconomic status, multiple risks and development of intelligence. In: Environmental Effects on Cognitive Abilities (Sternberg RJ, Grigorenko EL, eds). Mahwah, NJ:Lawrence Erlbaum Associates, 59-82.
49. Shannon M, Rifai N. 1997. The accuracy of a portable instrument for analysis of blood lead in children. Ambul Child Health 3:249-254.
50. Stoltzfus RJ, Heidkamp R, Kenkel D, Habicht JP. 2007. Iron supplementation of young children: learning from the new evidence. Food Nutr Bull 28(4 suppl):S572-S584.
51. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, et al. 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7(6):479-484.
52. Unger EL, Paul T, Murray-Kolb LE, Felt B, Jones BC, Beard JL. 2007. Early iron defciency alters sensorimotor development and brain monoamines in rats. J Nutr 137(1):118-124.
53. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline J, et al. 2007. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect 115:285-289.
54. Wong AH, Buckle CE, Van Tol HH. 2000. Polymorphisms in dop-amine receptors: what do they tell us? Eur J Pharmacol 410(2-3):183-203.
55. Wood S. 2006. Generalized Additive Models: An Introduction with R. Boca Raton, FL:Chapman and Hall/CRC Press.
56. Ye X, Fu H, Guidotti T. 2007. Environmental exposure and children's health in China. Arch Environ Occup Health 62(2):61-73.
57. Youdim MB, Ben-Shachar D, Yehuda S. 1989. Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am J Clin Nutr 50(3 suppl):607-617.
58. Zimmermann MB, Muthayya S, Moretti D, Kurpad A, Hurrell RF. 2006. Iron fortifcation reduces blood lead levels in children in Bangalore, India. Pediatrics 117(6):2014-2021.
59. Zuch CL, O'Mara DJ, Cory-Slechta DA. 1998. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment. Toxicol Appl Pharmacol 150(1):174-185.